| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in decreased expression of LPL mRNA" | 26377693 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of LPL mRNA" | 28903501 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of LPL mRNA" | 12021203 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl affects the expression of LPL mRNA" | 21703328 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | "2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of LPL mRNA" | 22763116 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | "2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of LPL mRNA" | 22763116 |
| C003585 | 22-hydroxycholesterol | 22-hydroxycholesterol results in increased expression of LPL mRNA | 16142410 |
| C003585 | 22-hydroxycholesterol | [alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of LPL mRNA | 16142410 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LPL mRNA" | 19114083 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of LPL mRNA" | 20959002 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LPL protein promotes the reaction [IFNG protein results in increased expression of GBP1 mRNA]] | 15994321 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LPL protein promotes the reaction [IFNG protein results in increased expression of ICAM1 mRNA]] | 15994321 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of LPL mRNA] | 15659569 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "2,5,2',5'-tetrachlorobiphenyl results in increased expression of LPL mRNA" | 21703328 |
| C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in decreased activity of LPL protein | 8567968 |
| C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in decreased expression of LPL mRNA | 8567968 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of LPL mRNA" | 12376462|1505992 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| C092561 | 2-octyl-4H-1,3,2-benzodioxaphosphorin-2-oxide | "2-octyl-4H-1,3,2-benzodioxaphosphorin-2-oxide results in decreased activity of LPL protein" | 16449251 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LPL mRNA" | 29216392 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LPL mRNA" | 23196670 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LPL mRNA" | 20959002 |
| C042413 | 4-(4'-chlorobenzyloxy)benzyl nicotinate | 4-(4'-chlorobenzyloxy)benzyl nicotinate results in increased expression of LPL protein | 4029807 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of LPL mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPL mRNA" | 27188386 |
| C082137 | 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide | 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide results in increased activity of LPL protein | 10628360 |
| C041594 | 4-nonylphenol | 4-nonylphenol results in increased expression of LPL mRNA | 24388992 |
| C105260 | 4-tert-octylphenol | 4-tert-octylphenol results in increased expression of LPL mRNA | 26382854 |
| C105260 | 4-tert-octylphenol | [nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of LPL mRNA | 28208108 |
| C573233 | 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one | "5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one results in increased expression of LPL mRNA" | 24646949 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPL mRNA" | 27188386 |
| C120038 | 9,10-dihydroxy-12-octadecenoic acid | "9,10-dihydroxy-12-octadecenoic acid results in increased expression of LPL mRNA" | 12021203 |
| C051208 | 9,10-epoxy-12-octadecenoic acid | "9,10-epoxy-12-octadecenoic acid results in increased expression of LPL mRNA" | 12021203 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of LPL mRNA | 15030884 |
| D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA | 17585979 |
| D000082 | Acetaminophen | LPL mRNA affects the susceptibility to Acetaminophen | 27530116 |
| D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA] | 17585979 |
| D000109 | Acetylcholine | LPL protein affects the susceptibility to Acetylcholine | 11786490 |
| D000255 | Adenosine Triphosphate | LPL protein affects the susceptibility to Adenosine Triphosphate | 11786490 |
| C006418 | adrenocorticotropin zinc | adrenocorticotropin zinc results in decreased expression of LPL mRNA | 19920212 |
| C560978 | aegeline | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA | 28843594 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of LPL mRNA | 23630614 |
| C103303 | alitretinoin | [alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of LPL mRNA | 16142410 |
| C103303 | alitretinoin | [alitretinoin co-treated with TO-901317] results in increased expression of LPL mRNA | 16142410 |
| C103303 | alitretinoin | alitretinoin results in increased expression of LPL mRNA | 16142410 |
| C518327 | aloe emodin | aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of LPL mRNA] | 22645054 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in increased expression of LPL mRNA | 16990341 |
| C040534 | alpha-hexachlorocyclohexane | alpha-hexachlorocyclohexane results in increased expression of LPL mRNA | 17785943 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of LPL mRNA | 16483693 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of LPL mRNA | 19128835|2670570 |
| D001280 | Atrazine | Atrazine results in decreased expression of LPL mRNA | 22982499 |
| D001553 | Benzbromarone | Benzbromarone results in increased expression of LPL protein | 18274627 |
| D001554 | Benzene | Benzene results in increased expression of LPL mRNA | 15120971|1512265 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LPL mRNA | 18164116 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of LPL mRNA | 20106945 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of LPL mRNA | 21569818 |
| D019207 | beta Carotene | beta Carotene results in decreased expression of LPL mRNA | 21569430 |
| D004958 | Estradiol | Estradiol affects the expression of LPL mRNA | 14699072 |
| D004958 | Estradiol | [Estradiol binds to ESR2 protein] which results in increased expression of LPL mRNA | 20404318 |
| D004958 | Estradiol | ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA] | 17974624 |
| D004958 | Estradiol | ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA] | 17974624 |
| D004958 | Estradiol | Estradiol results in decreased expression of LPL mRNA | 16643890 |
| D004958 | Estradiol | Estradiol results in increased expression of LPL mRNA | 17974624 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased expression of LPL mRNA] | 17974624 |
| D004958 | Estradiol | Progesterone inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| D004958 | Estradiol | Progesterone inhibits the reaction [ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| D004958 | Estradiol | Progesterone inhibits the reaction [Estradiol results in increased expression of LPL mRNA] | 17974624 |
| D004958 | Estradiol | Estradiol results in increased expression of LPL mRNA | 17522070 |
| D001629 | Bezafibrate | Bezafibrate results in increased activity of LPL protein | 11164425|8147947 |
| D001629 | Bezafibrate | Bezafibrate results in increased expression of LPL mRNA | 12782154|1912461 |
| D001629 | Bezafibrate | PPARA protein affects the reaction [Bezafibrate results in increased expression of LPL mRNA] | 12782154 |
| D001629 | Bezafibrate | PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of LPL mRNA] | 19124612 |
| D001629 | Bezafibrate | Bezafibrate inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] | 17379010 |
| D001629 | Bezafibrate | Bezafibrate results in increased activity of LPL protein | 2907502|9006809 |
| D001629 | Bezafibrate | [Bezafibrate results in increased activity of LPL protein] which results in decreased abundance of Triglycerides | 9006809 |
| D001629 | Bezafibrate | Bezafibrate results in increased activity of LPL protein | 10628360|1737901 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased expression of LPL mRNA | 27003841|2768578 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased expression of LPL protein | 27003841 |
| C543008 | bis(4-hydroxyphenyl)sulfone | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| C543008 | bis(4-hydroxyphenyl)sulfone | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of LPL mRNA | 22662114 |
| C006780 | bisphenol A | [bisphenol A results in decreased expression of LPL mRNA] which affects the abundance of Triglycerides | 22662114 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LPL mRNA | 23090578|2514347 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LPL protein | 25143472 |
| C006780 | bisphenol A | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of LPL mRNA] | 15659569 |
| C006780 | bisphenol A | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| C006780 | bisphenol A | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| C006780 | bisphenol A | [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| C006780 | bisphenol A | [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| C006780 | bisphenol A | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of LPL mRNA | 27502578 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LPL mRNA | 15659569 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of LPL mRNA | 28938450 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LPL mRNA | 28938450 |
| C006780 | bisphenol A | bisphenol A affects the expression of LPL mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of LPL mRNA | 25181051|2865753 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LPL mRNA | 20019905|2574866 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LPL mRNA | 26382854 |
| C006780 | bisphenol A | [nonylphenol co-treated with bisphenol A] results in increased expression of LPL mRNA | 28208108 |
| C512161 | bisphenol A glucuronide | bisphenol A glucuronide results in increased expression of LPL mRNA | 26018136 |
| C512161 | bisphenol A glucuronide | bisphenol A glucuronide results in increased expression of LPL protein | 26018136 |
| C512161 | bisphenol A glucuronide | fulvestrant inhibits the reaction [bisphenol A glucuronide results in increased expression of LPL protein] | 26018136 |
| C584056 | BMS-764459 | BMS-764459 results in decreased expression of LPL mRNA | 23831372 |
| C057368 | BRL 37344 | BRL 37344 results in increased expression of LPL mRNA | 9032464 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in decreased activity of LPL protein | 9414485 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LPL mRNA | 9032464 |
| C027561 | butylbenzyl phthalate | [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of LPL mRNA | 26820058 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of LPL mRNA | 15336504 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in decreased expression of LPL mRNA | 23221991 |
| D002104 | Cadmium | myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein] | 25240712 |
| D002104 | Cadmium | [Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein | 25240712 |
| D002104 | Cadmium | Cadmium results in decreased expression of LPL mRNA | 24095957 |
| D002104 | Cadmium | Cadmium results in increased activity of LPL protein | 24095957 |
| D019256 | Cadmium Chloride | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LPL mRNA | 19840844 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased activity of LPL protein | 18329778 |
| C037123 | cadmium sulfate | cadmium sulfate affects the reaction [MTF1 affects the expression of LPL mRNA] | 16221973 |
| D002110 | Caffeine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA | 28843594 |
| D002110 | Caffeine | Caffeine results in decreased expression of LPL mRNA | 23727198 |
| D002110 | Caffeine | Caffeine results in decreased expression of LPL mRNA | 23727198 |
| C459604 | candoxin | candoxin results in decreased expression of LPL mRNA | 16309724 |
| D000074262 | Canola Oil | Canola Oil affects the expression of LPL mRNA | 16177195 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of LPL mRNA | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of LPL mRNA | 27339419 |
| D002251 | Carbon Tetrachloride | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of LPL mRNA] | 16006527 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of LPL mRNA | 17522070 |
| C054133 | casticin | casticin results in decreased expression of LPL mRNA | 27862857 |
| D002392 | Catechin | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of LPL mRNA | 24763279 |
| D002392 | Catechin | Catechin inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] | 23365609 |
| C033394 | CGP 12177 | CGP 12177 results in increased expression of LPL mRNA | 9032464 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of LPL mRNA | 23650126 |
| D002725 | Chloroform | Chloroform results in increased expression of LPL mRNA | 17522070 |
| D002726 | Chlorogenic Acid | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D002726 | Chlorogenic Acid | [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of LPL mRNA | 21356183 |
| D004390 | Chlorpyrifos | [Copper co-treated with Chlorpyrifos] results in increased expression of LPL mRNA | 21356183 |
| D002772 | Cholera Toxin | Cholera Toxin results in increased expression of LPL mRNA | 9032464 |
| C011724 | cholest-5-en-3 beta,7 alpha-diol | "cholest-5-en-3 beta,7 alpha-diol results in decreased activity of LPL protein" | 8567968 |
| C011724 | cholest-5-en-3 beta,7 alpha-diol | "cholest-5-en-3 beta,7 alpha-diol results in decreased expression of LPL mRNA" | 8567968 |
| D002784 | Cholesterol | Cholesterol results in increased expression of LPL mRNA | 26296894 |
| D002791 | Cholesterol, Dietary | "[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of LPL mRNA" | 14684380 |
| D002791 | Cholesterol, Dietary | "[Cholesterol, Dietary co-treated with Dietary Carbohydrates] results in decreased expression of LPL mRNA" | 22579924 |
| D002791 | Cholesterol, Dietary | "Cholesterol, Dietary results in decreased expression of LPL mRNA" | 22579924 |
| D002791 | Cholesterol, Dietary | "Cholesterol, Dietary results in increased expression of LPL mRNA" | 14684380 |
| D002791 | Cholesterol, Dietary | "Plant Preparations inhibits the reaction [Cholesterol, Dietary results in decreased expression of LPL mRNA]" | 22579924 |
| D008076 | Cholesterol, HDL | "LPL gene polymorphism affects the abundance of Cholesterol, HDL" | 16030523 |
| D019826 | Cholic Acid | "[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of LPL mRNA" | 14684380 |
| D002794 | Choline | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA | 25178843 |
| D002794 | Choline | Choline inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA] | 25178843 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPL mRNA | 20938992 |
| D002794 | Choline | Methionine inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA] | 25178843 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of LPL mRNA | 18353800 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of LPL mRNA | 21401097 |
| C019304 | ciprofibrate | ciprofibrate results in increased activity of LPL protein | 8593127 |
| C019304 | ciprofibrate | ciprofibrate results in increased expression of LPL mRNA | 12771043 |
| C014282 | cirazoline | cirazoline promotes the reaction [Isoproterenol results in increased expression of LPL mRNA] | 9032464 |
| D002994 | Clofibrate | Clofibrate results in increased expression of LPL mRNA | 17495091 |
| D002994 | Clofibrate | Clofibrate results in increased activity of LPL protein | 417937|8593127 |
| D002994 | Clofibrate | Clofibrate results in increased expression of LPL protein | 226883 |
| D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA | 17585979 |
| D002994 | Clofibrate | Clofibrate results in increased expression of LPL mRNA | 23811191 |
| D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPL mRNA] | 17585979 |
| D002994 | Clofibrate | Clofibrate results in increased expression of LPL mRNA | 12851107|1752207 |
| D003024 | Clozapine | Clozapine results in decreased expression of LPL mRNA | 19682446 |
| D003024 | Clozapine | Clozapine results in decreased expression of LPL protein | 19682446 |
| D003024 | Clozapine | Clozapine results in increased expression of LPL mRNA | 17266109 |
| C004690 | coclaurine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA | 28843594 |
| D005576 | Colforsin | Colforsin results in increased expression of LPL mRNA | 9032464 |
| D003300 | Copper | [Copper co-treated with Chlorpyrifos] results in increased expression of LPL mRNA | 21356183 |
| D003300 | Copper | Copper results in increased expression of LPL mRNA | 21356183 |
| D019327 | Copper Sulfate | Copper Sulfate affects the expression of LPL protein | 23660017 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of LPL mRNA | 26577399 |
| D003474 | Curcumin | Curcumin affects the expression of LPL mRNA | 27208389 |
| D003571 | Cytochalasin B | Cytochalasin B results in decreased activity of LPL protein | 9414485 |
| D003634 | DDT | DDT results in increased expression of LPL mRNA | 25014179 |
| C017180 | decamethrin | decamethrin results in decreased expression of LPL mRNA | 23401056 |
| D013759 | Dronabinol | Dronabinol results in increased expression of LPL mRNA | 18163980 |
| D013759 | Dronabinol | Dronabinol results in decreased expression of LPL mRNA | 21955143 |
| D003840 | Deoxycholic Acid | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of LPL mRNA | 16556975 |
| D017485 | 1-Deoxynojirimycin | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA] | 25446853 |
| D064791 | Desoxycorticosterone Acetate | "[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA" | 22228705 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of LPL mRNA] | 27941970 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA | 19186324 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of LPL mRNA | 25047013|2700384 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of LPL protein | 27003841 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LPL mRNA | 28628672 |
| D003907 | Dexamethasone | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| D003907 | Dexamethasone | [rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 20206132 |
| D003907 | Dexamethasone | rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 19186324 |
| D003907 | Dexamethasone | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| D003907 | Dexamethasone | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| D003907 | Dexamethasone | TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 20206132 |
| D003907 | Dexamethasone | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| D003907 | Dexamethasone | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of LPL mRNA | 22733784 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 9543393 |
| D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA | 16054899 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of LPL protein] | 9414485 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of LPL protein | 26018136 |
| D003907 | Dexamethasone | Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D003907 | Dexamethasone | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 23086663 |
| D003907 | Dexamethasone | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| D003907 | Dexamethasone | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA] | 16054899 |
| D003907 | Dexamethasone | tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D003907 | Dexamethasone | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 23086663 |
| D003907 | Dexamethasone | Dexamethasone results in increased activity of LPL protein | 12906939 |
| D003907 | Dexamethasone | Progesterone inhibits the reaction [Dexamethasone results in increased activity of LPL protein] | 12906939 |
| D002945 | Cisplatin | Cisplatin results in increased expression of LPL mRNA | 27594783 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of LPL mRNA | 22023808 |
| D004006 | Dichlorvos | Dichlorvos results in decreased activity of LPL protein | 3196159 |
| D004008 | Diclofenac | Diclofenac results in increased expression of LPL mRNA | 26934552 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of LPL mRNA | 26924002 |
| D018119 | Stavudine | [Stavudine co-treated with Lamivudine] affects the expression of LPL mRNA | 11741158 |
| D018119 | Stavudine | [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA | 11741158 |
| D018119 | Stavudine | [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA | 11741158 |
| D019259 | Lamivudine | Lamivudine results in decreased expression of LPL mRNA | 11741158 |
| D019259 | Lamivudine | [Stavudine co-treated with Lamivudine] affects the expression of LPL mRNA | 11741158 |
| D019259 | Lamivudine | [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA | 11741158 |
| D019259 | Lamivudine | [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA | 11741158 |
| D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA | 11741158 |
| D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of LPL mRNA | 11741158 |
| D004040 | Dietary Carbohydrates | "[Cholesterol, Dietary co-treated with Dietary Carbohydrates] results in decreased expression of LPL mRNA" | 22579924 |
| D004041 | Dietary Fats | [resveratrol analog co-treated with Dietary Fats] affects the expression of LPL mRNA | 24759758 |
| D004041 | Dietary Fats | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA] | 25446853 |
| D004041 | Dietary Fats | [AGT protein affects the susceptibility to Dietary Fats] which affects the expression of LPL mRNA | 26704350 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sugars] results in decreased expression of LPL mRNA | 28611668 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA | 25446853 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of LPL mRNA | 25016146 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of LPL mRNA | 15238619|1635704 |
| D004041 | Dietary Fats | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in decreased expression of LPL mRNA] | 28611668 |
| D004041 | Dietary Fats | Catechin inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] | 23365609 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of LPL protein | 25087745 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of LPL mRNA | 23365609|2353752 |
| D004041 | Dietary Fats | orlistat inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] | 25087745 |
| D004041 | Dietary Fats | piperine inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] | 25087745 |
| D004041 | Dietary Fats | Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] | 23365609 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of LPL mRNA | 21852083 |
| D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] | 21852083 |
| D004042 | Dietary Fats, Unsaturated | "Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of LPL mRNA]" | 23626681 |
| D000073417 | Dietary Sugars | [Dietary Fats co-treated with Dietary Sugars] results in decreased expression of LPL mRNA | 28611668 |
| D000073417 | Dietary Sugars | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in decreased expression of LPL mRNA] | 28611668 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of LPL mRNA | 19245819 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LPL mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of LPL mRNA | 12771043|2453584 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LPL mRNA | 18164116 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of LPL mRNA | 22710028 |
| D004054 | Diethylstilbestrol | [troglitazone co-treated with Diethylstilbestrol] results in increased expression of LPL protein | 22710028 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of LPL mRNA | 16368784 |
| D002117 | Calcitriol | troglitazone inhibits the reaction [Calcitriol results in decreased expression of LPL mRNA] | 16368784 |
| C042080 | diisodecyl phthalate | diisodecyl phthalate results in increased expression of LPL mRNA | 25825955 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LPL mRNA" | 12376462 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of LPL mRNA | 25380136 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in increased expression of LPL mRNA | 26924002 |
| C550453 | dioxinodehydroeckol | dioxinodehydroeckol results in decreased expression of LPL mRNA | 20385110 |
| C076126 | disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate | "disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate results in increased expression of LPL mRNA" | 20184727 |
| D004237 | Diuron | Diuron results in decreased expression of LPL mRNA | 25152437 |
| C098320 | efavirenz | efavirenz results in decreased expression of LPL mRNA | 21619898 |
| C118739 | entinostat | entinostat results in decreased expression of LPL mRNA | 27188386 |
| D004918 | Erythromycin Estolate | Erythromycin Estolate results in increased expression of LPL mRNA | 17522070 |
| D004967 | Estrogens | [Estrogens co-treated with Progestins] results in increased expression of LPL protein | 3312052 |
| D004967 | Estrogens | Estrogens results in increased expression of LPL mRNA | 25014179 |
| D000431 | Ethanol | Ethanol results in decreased expression of LPL mRNA | 22173916 |
| D000431 | Ethanol | Ethanol results in increased expression of LPL mRNA | 21955143 |
| D000431 | Ethanol | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of LPL mRNA] | 22173916 |
| D000431 | Ethanol | Ethanol results in decreased activity of LPL protein | 28442378 |
| D000431 | Ethanol | zingerone inhibits the reaction [Ethanol results in decreased activity of LPL protein] | 28442378 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of LPL mRNA | 20227414 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of LPL mRNA | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of LPL mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPL mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of LPL mRNA | 17557909 |
| C504648 | ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate | "ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate results in increased expression of LPL mRNA" | 15997096 |
| C100419 | ethyl octylphosphonofluoridate | ethyl octylphosphonofluoridate results in decreased activity of LPL protein | 16449251 |
| C009746 | etofibrate | [etofibrate co-treated with Heparin] results in increased secretion of LPL protein | 3179329 |
| D005227 | Fatty Acids | LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose] | 20628023 |
| D005230 | Fatty Acids, Nonesterified | "LPL protein affects the abundance of Fatty Acids, Nonesterified" | 11786490 |
| D005231 | Fatty Acids, Unsaturated | "[LPL protein results in increased hydrolysis of very low density lipoprotein triglyceride] which results in increased abundance of Fatty Acids, Unsaturated" | 18435438 |
| D011345 | Fenofibrate | Fenofibrate results in increased activity of LPL protein | 8593127 |
| D011345 | Fenofibrate | Fenofibrate results in increased expression of LPL mRNA | 11798191 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Pyrazinamide results in decreased expression of LPL mRNA] | 27071702 |
| D011345 | Fenofibrate | Fenofibrate results in increased expression of LPL mRNA | 16595124|2707170 |
| D058607 | Fibric Acids | Fibric Acids results in increased activity of LPL protein | 8497455 |
| D058607 | Fibric Acids | [Fibric Acids binds to and results in increased activity of PPARA protein] which results in increased activity of LPL protein | 16511610 |
| D058607 | Fibric Acids | Fibric Acids results in increased activity of LPL protein | 2045526|9515185 |
| D058607 | Fibric Acids | Fibric Acids results in increased expression of LPL | 11123853 |
| D058607 | Fibric Acids | [[Fibric Acids results in increased expression of LPL] co-treated with [Fibric Acids results in decreased expression of APOC3]] results in decreased abundance of Triglycerides | 11123853 |
| C065180 | fluvastatin | [ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin | 19773416 |
| C065180 | fluvastatin | [APOB gene SNP co-treated with APOE gene SNP co-treated with HMGCR gene SNP co-treated with LDLR gene SNP co-treated with PCSK9 gene SNP co-treated with ABCA1 gene SNP co-treated with CETP gene SNP co-treated with LIPC gene SNP co-treated with LPL gene SNP] affects the susceptibility to fluvastatin | 19773416 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPL mRNA | 20938992 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [bisphenol A glucuronide results in increased expression of LPL protein] | 26018136 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased expression of LPL mRNA] | 17974624 |
| C070081 | fulvestrant | fulvestrant results in decreased expression of LPL mRNA | 17974624 |
| C056933 | fumonisin B1 | fumonisin B1 results in increased expression of LPL mRNA | 16221962 |
| C039281 | furan | furan results in decreased methylation of LPL gene | 27387713 |
| C039281 | furan | furan results in increased expression of LPL mRNA | 27387713 |
| D015248 | Gemfibrozil | Gemfibrozil results in increased activity of LPL protein | 8593127 |
| D015248 | Gemfibrozil | Gemfibrozil results in increased expression of LPL mRNA | 21195106 |
| D015248 | Gemfibrozil | Gemfibrozil results in increased activity of LPL protein | 9006809 |
| D015248 | Gemfibrozil | [Gemfibrozil results in increased activity of LPL protein] which results in decreased abundance of Triglycerides | 9006809 |
| D019833 | Genistein | Genistein results in decreased activity of LPL protein | 9414485 |
| D019833 | Genistein | Genistein results in increased expression of LPL mRNA | 21782745 |
| C507965 | ginsenoside 20S-protopanaxatriol | ginsenoside 20S-protopanaxatriol results in increased secretion of LPL protein | 8988629 |
| C048026 | ginsenoside Rb2 | ginsenoside Rb2 results in decreased secretion of LPL protein | 8988629 |
| C048026 | ginsenoside Rb2 | ginsenoside Rb2 results in increased secretion of LPL protein | 8988629 |
| C049863 | ginsenoside Rd | ginsenoside Rd results in decreased secretion of LPL protein | 8988629 |
| C049864 | ginsenoside Re | ginsenoside Re results in increased secretion of LPL protein | 8988629 |
| C035054 | ginsenoside Rg1 | ginsenoside Rg1 results in increased secretion of LPL protein | 8988629 |
| C425564 | ginsenoside Rh1 | ginsenoside Rh1 results in increased secretion of LPL protein | 8988629 |
| C064378 | ginsenoside Ro | ginsenoside Ro results in increased secretion of LPL protein | 8988629 |
| C030691 | gluconic acid | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of LPL mRNA | 16556975 |
| C046905 | glucosamine 6-O-sulfate | glucosamine 6-O-sulfate results in decreased expression of LPL mRNA | 19520133 |
| C001293 | glucosamine 6-phosphate | glucosamine 6-phosphate results in decreased expression of LPL mRNA | 19427183 |
| D005947 | Glucose | LPL protein promotes the reaction [Fatty Acids results in increased uptake of Glucose] | 20628023 |
| D005947 | Glucose | Glucose analog results in decreased activity of LPL protein | 9414485 |
| D005947 | Glucose | [INS protein co-treated with Glucose] results in increased expression of LPL mRNA | 22634610 |
| C511402 | Grape Seed Proanthocyanidins | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of LPL mRNA | 24763279 |
| D006118 | Griseofulvin | Griseofulvin affects the expression of LPL mRNA | 12735108 |
| C119543 | GW0072 | GW0072 results in increased expression of LPL mRNA | 12021203 |
| C401311 | GW 7845 | GW 7845 results in increased expression of LPL mRNA | 20519739 |
| D006493 | Heparin | [etofibrate co-treated with Heparin] results in increased secretion of LPL protein | 3179329 |
| D006534 | Heptachlor Epoxide | Heptachlor Epoxide results in decreased expression of LPL mRNA | 25270620 |
| C013015 | hesperetin | hesperetin results in decreased expression of LPL mRNA | 25345581 |
| C012348 | higenamine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA | 28843594 |
| D006854 | Hydrocortisone | Hydrocortisone results in decreased activity of and results in decreased expression of LPL protein | 17549480 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of LPL mRNA | 26339600 |
| D047348 | Hydrolyzable Tannins | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA | 28843594 |
| C495366 | hydroxyoctadecadienoic acid | hydroxyoctadecadienoic acid results in increased expression of LPL mRNA | 12021203 |
| D007052 | Ibuprofen | Ibuprofen results in decreased expression of LPL mRNA | 28201806 |
| C071909 | ICI D7114 | ICI D7114 results in increased expression of LPL mRNA | 9032464 |
| D019469 | Indinavir | Indinavir results in decreased activity of LPL protein | 11786383 |
| D019469 | Indinavir | Indinavir results in increased expression of LPL mRNA | 11741158 |
| D019469 | Indinavir | [Stavudine co-treated with Lamivudine co-treated with Indinavir] affects the expression of LPL mRNA | 11741158 |
| D019469 | Indinavir | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA | 11741158 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of LPL mRNA | 21396975 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LPL mRNA | 28628672 |
| D007213 | Indomethacin | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| D007213 | Indomethacin | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| D007213 | Indomethacin | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| D007213 | Indomethacin | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [APC gene mutant form results in decreased expression of LPL mRNA] | 17546600 |
| D007306 | Insecticides | Insecticides results in decreased expression of LPL mRNA | 23401056 |
| C541917 | INT 131 | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in decreased expression of LPL mRNA] | 28611668 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LPL mRNA | 25613284 |
| D015056 | 1-Methyl-3-isobutylxanthine | [1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of LPL mRNA | 27003841 |
| D015056 | 1-Methyl-3-isobutylxanthine | 1-Methyl-3-isobutylxanthine results in increased expression of LPL mRNA | 22645054 |
| D015056 | 1-Methyl-3-isobutylxanthine | aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of LPL mRNA] | 22645054 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA | 19186324 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LPL mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | [rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 20206132 |
| D015056 | 1-Methyl-3-isobutylxanthine | rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 19186324 |
| D015056 | 1-Methyl-3-isobutylxanthine | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 20206132 |
| D015056 | 1-Methyl-3-isobutylxanthine | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of LPL mRNA | 26820058 |
| D015056 | 1-Methyl-3-isobutylxanthine | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | 2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | 2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | 2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D015056 | 1-Methyl-3-isobutylxanthine | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| D015056 | 1-Methyl-3-isobutylxanthine | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA] | 16054899 |
| D015056 | 1-Methyl-3-isobutylxanthine | tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| D015056 | 1-Methyl-3-isobutylxanthine | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 23086663 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of LPL mRNA | 21335049 |
| D007545 | Isoproterenol | cirazoline promotes the reaction [Isoproterenol results in increased expression of LPL mRNA] | 9032464 |
| D007545 | Isoproterenol | Isoproterenol results in decreased activity of LPL protein | 16906524 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of LPL mRNA | 9032464 |
| D007545 | Isoproterenol | naringin inhibits the reaction [Isoproterenol results in decreased activity of LPL protein] | 16906524 |
| C098607 | JP8 aviation fuel | JP8 aviation fuel results in increased expression of LPL protein | 17337753 |
| C561695 | (+)-JQ1 compound | [PD 0325901 co-treated with (+)-JQ1 compound] results in decreased expression of LPL mRNA | 25119042 |
| C008261 | lead acetate | lead acetate results in increased expression of LPL mRNA | 21829687 |
| C045463 | leflunomide | leflunomide results in increased expression of LPL mRNA | 24136188 |
| D044243 | Linoleic Acids, Conjugated | "Linoleic Acids, Conjugated results in increased activity of LPL protein" | 23073171 |
| D044243 | Linoleic Acids, Conjugated | "Linoleic Acids, Conjugated results in decreased expression of LPL mRNA" | 17322064 |
| D044243 | Linoleic Acids, Conjugated | "rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of LPL mRNA]" | 17322064 |
| D008055 | Lipids | [troglitazone results in increased expression of LPL protein] which results in increased metabolism of Lipids | 10233209 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of LPL mRNA | 21873422 |
| D008070 | Lipopolysaccharides | pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] | 21873422 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of LPL mRNA | 25613284 |
| D008070 | Lipopolysaccharides | Bezafibrate inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] | 17379010 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of LPL mRNA | 17379010 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in increased expression of LPL mRNA | 20359477 |
| D008148 | Lovastatin | Lovastatin affects the expression of LPL mRNA | 27208389 |
| D008345 | Manganese | Manganese results in decreased activity of LPL protein | 17040939 |
| C013592 | mangiferin | mangiferin results in increased expression of LPL mRNA | 22038976 |
| C013592 | mangiferin | mangiferin results in increased activity of LPL protein | 15975614 |
| C013592 | mangiferin | mangiferin results in increased expression of LPL mRNA | 15975614 |
| C013592 | mangiferin | MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein] | 15975614 |
| C013592 | mangiferin | MK-886 inhibits the reaction [mangiferin results in increased expression of LPL mRNA] | 15975614 |
| D008550 | Melatonin | Melatonin results in decreased expression of LPL mRNA | 20738756 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of LPL mRNA | 28935588 |
| D008715 | Methionine | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA | 25178843 |
| D008715 | Methionine | Choline inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA] | 25178843 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPL mRNA | 20938992 |
| D008715 | Methionine | Methionine inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of LPL mRNA] | 25178843 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of LPL mRNA | 23103053 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of LPL mRNA | 28001369 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of LPL mRNA | 21628967 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of LPL mRNA | 19840844 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LPL mRNA | 19840844 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LPL mRNA | 19840844 |
| D015735 | Mifepristone | Mifepristone results in increased expression of LPL protein | 26018136 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of LPL mRNA | 25972201 |
| C060893 | MK-886 | MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein] | 15975614 |
| C060893 | MK-886 | MK-886 inhibits the reaction [mangiferin results in increased expression of LPL mRNA] | 15975614 |
| C060893 | MK-886 | MK-886 inhibits the reaction [Plant Extracts results in increased activity of LPL protein] | 15975614 |
| C060893 | MK-886 | MK-886 inhibits the reaction [Plant Extracts results in increased expression of LPL mRNA] | 15975614 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of LPL mRNA | 26924002 |
| D009020 | Morphine | Morphine results in increased expression of LPL mRNA | 21955143 |
| C040015 | myricetin | myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein] | 25240712 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of LPL mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of LPL mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of LPL mRNA" | 25620056 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of LPL mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of LPL mRNA | 17522070|2538013 |
| C005274 | naringin | naringin inhibits the reaction [Isoproterenol results in decreased activity of LPL protein] | 16906524 |
| C017096 | n-butoxyethanol | n-butoxyethanol results in decreased expression of LPL mRNA | 19812364 |
| D019888 | Nelfinavir | Nelfinavir results in decreased expression of LPL mRNA | 11741158 |
| D019888 | Nelfinavir | [Stavudine co-treated with Lamivudine co-treated with Nelfinavir] results in decreased expression of LPL mRNA | 11741158 |
| D019829 | Nevirapine | Nevirapine results in increased expression of LPL mRNA | 21619898 |
| D009532 | Nickel | Nickel results in decreased expression of LPL mRNA | 24768652|2558310 |
| D009538 | Nicotine | Nicotine results in increased expression of LPL mRNA | 21955143 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of LPL mRNA | 17616710 |
| C025256 | nonylphenol | [nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of LPL mRNA | 28208108 |
| C025256 | nonylphenol | [nonylphenol co-treated with bisphenol A] results in increased expression of LPL mRNA | 28208108 |
| C025256 | nonylphenol | nonylphenol results in increased expression of LPL mRNA | 26382854 |
| D009638 | Norepinephrine | Norepinephrine results in increased expression of LPL mRNA | 9032464 |
| D009638 | Norepinephrine | Prazosin inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] | 9032464 |
| D009638 | Norepinephrine | Propranolol inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] | 9032464 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of LPL | 20590410 |
| D019319 | Okadaic Acid | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of LPL mRNA | 19840844 |
| C108709 | oleoyl-estrone | oleoyl-estrone results in decreased expression of LPL mRNA | 17725831|1932603 |
| C055122 | orlistat | orlistat inhibits the reaction [LPL protein results in decreased activity of TNF protein] | 15994321 |
| C055122 | orlistat | orlistat inhibits the reaction [[LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides] | 15910848 |
| C055122 | orlistat | orlistat inhibits the reaction [very low density lipoprotein triglyceride results in increased activity of LPL protein] | 12573449 |
| C055122 | orlistat | orlistat results in decreased activity of LPL protein | 15994321|1869814 |
| C055122 | orlistat | orlistat results in decreased activity of LPL protein | 12388125 |
| C055122 | orlistat | [orlistat results in decreased activity of LPL protein] which affects the uptake of Triglycerides | 12388125 |
| C055122 | orlistat | orlistat inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] | 25087745 |
| C055122 | orlistat | orlistat results in decreased activity of LPL protein | 17517063|1807973 |
| D009966 | Orphenadrine | Orphenadrine affects the expression of LPL mRNA | 23665939 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of LPL mRNA | 25729387 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of LPL mRNA | 25729387 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of LPL mRNA | 24236059 |
| D010269 | Paraquat | Paraquat results in decreased expression of LPL mRNA | 17077588 |
| C506614 | PD 0325901 | [PD 0325901 co-treated with (+)-JQ1 compound] results in decreased expression of LPL mRNA | 25119042 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of LPL mRNA | 26705709 |
| C471071 | perfluorohexanesulfonic acid | perfluorohexanesulfonic acid results in increased expression of LPL mRNA | 21705711|2804904 |
| C471071 | perfluorohexanesulfonic acid | PPARA gene mutant form inhibits the reaction [perfluorohexanesulfonic acid results in increased expression of LPL mRNA] | 28049043 |
| C101816 | perfluoro-n-nonanoic acid | perfluoro-n-nonanoic acid results in decreased expression of LPL mRNA | 21984479 |
| C584865 | perfluorononanoic acid | perfluorononanoic acid results in increased expression of LPL mRNA | 28049043 |
| C584865 | perfluorononanoic acid | PPARA gene mutant form inhibits the reaction [perfluorononanoic acid results in increased expression of LPL mRNA] | 28049043 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of LPL mRNA | 23306105 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of LPL mRNA | 28011154 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of LPL mRNA | 21705711|2654859 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of LPL mRNA | 18692542 |
| C023036 | perfluorooctanoic acid | "Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of LPL mRNA]" | 23626681 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of LPL mRNA | 23626681|2509218 |
| C023036 | perfluorooctanoic acid | PPARA gene mutant form inhibits the reaction [perfluorooctanoic acid results in increased expression of LPL mRNA] | 28049043 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of LPL mRNA | 16221955|1916217 |
| D026023 | Permethrin | Permethrin results in increased expression of LPL mRNA | 24911977 |
| D010622 | Phencyclidine | Phencyclidine results in increased expression of LPL mRNA | 17266109 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LPL mRNA | 24535843 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LPL mRNA] | 19482888 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of LPL mRNA | 19136022|2309116 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of LPL mRNA | 19482888 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of LPL mRNA | 22008526|2200853 |
| C047088 | phenylamil | phenylamil results in increased expression of LPL mRNA | 20519739 |
| D010656 | Phenylephrine | LPL protein affects the susceptibility to Phenylephrine | 11786490 |
| D010852 | Picrotoxin | Picrotoxin results in decreased expression of LPL mRNA | 15170462 |
| C008922 | piperine | piperine inhibits the reaction [Dietary Fats results in decreased expression of LPL protein] | 25087745 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of LPL mRNA | 19136022 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of LPL mRNA | 18445702 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of LPL mRNA | 11798191|1537516 |
| C006253 | pirinixic acid | PPARA gene mutant form inhibits the reaction [pirinixic acid results in increased expression of LPL mRNA] | 28049043 |
| C006253 | pirinixic acid | PPARA protein affects the reaction [pirinixic acid results in increased expression of LPL mRNA] | 16221962 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of LPL mRNA] | 17950772|2005976 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of LPL mRNA | 19162173 |
| D010936 | Plant Extracts | MK-886 inhibits the reaction [Plant Extracts results in increased activity of LPL protein] | 15975614 |
| D010936 | Plant Extracts | MK-886 inhibits the reaction [Plant Extracts results in increased expression of LPL mRNA] | 15975614 |
| D010936 | Plant Extracts | Plant Extracts results in increased activity of LPL protein | 15975614 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of LPL mRNA | 15975614 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of LPL mRNA | 25086370 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of LPL mRNA | 21392566 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] | 23365609 |
| D028321 | Plant Preparations | "Plant Preparations inhibits the reaction [Cholesterol, Dietary results in decreased expression of LPL mRNA]" | 22579924 |
| D059808 | Polyphenols | Polyphenols results in decreased expression of LPL mRNA | 16293270 |
| D011134 | Polysaccharides | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA] | 25446853 |
| C042829 | ponalrestat | ponalrestat results in increased activity of LPL protein | 10628360 |
| D011189 | Potassium Chloride | LPL protein results in increased susceptibility to Potassium Chloride | 11786490 |
| D011189 | Potassium Chloride | "[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA" | 22228705 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of LPL mRNA | 27225895 |
| D017035 | Pravastatin | Pravastatin results in decreased expression of LPL mRNA | 27225895 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] | 9032464 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of LPL mRNA | 19162173 |
| D011374 | Progesterone | Progesterone results in decreased expression of LPL mRNA | 23018184 |
| D011374 | Progesterone | Progesterone affects the expression of LPL mRNA | 17251523 |
| D011374 | Progesterone | Progesterone inhibits the reaction [ESR1 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| D011374 | Progesterone | Progesterone inhibits the reaction [ESR2 protein promotes the reaction [Estradiol results in increased expression of LPL mRNA]] | 17974624 |
| D011374 | Progesterone | Progesterone inhibits the reaction [Estradiol results in increased expression of LPL mRNA] | 17974624 |
| D011374 | Progesterone | Progesterone results in decreased expression of LPL mRNA | 17974624 |
| D011374 | Progesterone | Progesterone results in decreased expression of LPL mRNA | 19690047 |
| D011374 | Progesterone | Progesterone inhibits the reaction [Dexamethasone results in increased activity of LPL protein] | 12906939 |
| D011374 | Progesterone | Progesterone results in increased expression of LPL mRNA | 20726854 |
| D011372 | Progestins | [Estrogens co-treated with Progestins] results in increased expression of LPL protein | 3312052 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Norepinephrine results in increased expression of LPL mRNA] | 9032464 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of LPL mRNA | 24780913 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in decreased expression of LPL mRNA | 29127035 |
| D011718 | Pyrazinamide | Fenofibrate inhibits the reaction [Pyrazinamide results in decreased expression of LPL mRNA] | 27071702 |
| D011718 | Pyrazinamide | Pyrazinamide results in decreased expression of LPL mRNA | 27071702 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in decreased expression of LPL mRNA] | 21873422 |
| C432165 | pyrazolanthrone | pyrazolanthrone results in increased expression of LPL mRNA | 21873422 |
| D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of LPL mRNA | 19059307 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in increased expression of LPL mRNA | 16643890 |
| C059514 | resveratrol | resveratrol results in decreased expression of LPL mRNA | 16901463 |
| C059514 | resveratrol | [resveratrol analog co-treated with Dietary Fats] affects the expression of LPL mRNA | 24759758 |
| C059514 | resveratrol | resveratrol metabolite results in decreased expression of LPL mRNA | 22945685 |
| C059514 | resveratrol | resveratrol results in decreased expression of LPL mRNA | 18555852|2472235 |
| C059514 | resveratrol | resveratrol results in decreased activity of LPL protein | 21569266|2401239 |
| C059514 | resveratrol | resveratrol results in decreased expression of LPL mRNA | 23848300|2401239 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of LPL mRNA] | 21852083 |
| D019438 | Ritonavir | Ritonavir affects the expression of LPL mRNA | 11741158 |
| C089730 | rosiglitazone | rosiglitazone affects the transport of LPL protein | 16896939 |
| C089730 | rosiglitazone | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| C089730 | rosiglitazone | [rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 20206132 |
| C089730 | rosiglitazone | rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 19186324 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of LPL mRNA | 12814394|1527740 |
| C089730 | rosiglitazone | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| C089730 | rosiglitazone | TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 20206132 |
| C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA] | 27273607 |
| C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein] | 27273607 |
| C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA | 16054899 |
| C089730 | rosiglitazone | rosiglitazone affects the expression of LPL protein | 21347706 |
| C089730 | rosiglitazone | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 23086663 |
| C089730 | rosiglitazone | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL mRNA | 27273607 |
| C089730 | rosiglitazone | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of LPL protein | 27273607 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of LPL mRNA] | 22173916 |
| C089730 | rosiglitazone | "rosiglitazone inhibits the reaction [Linoleic Acids, Conjugated results in decreased expression of LPL mRNA]" | 17322064 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of LPL mRNA | 11916924|1202120 |
| C089730 | rosiglitazone | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA] | 16054899 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of LPL mRNA | 19520784 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of LPL mRNA | 15887043|2151530 |
| D012402 | Rotenone | Rotenone results in decreased expression of LPL mRNA | 19693701 |
| D019258 | Saquinavir | Saquinavir results in decreased activity of LPL protein | 11786383 |
| D019258 | Saquinavir | Saquinavir results in decreased expression of LPL mRNA | 11741158 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of LPL | 19216230 |
| D019821 | Simvastatin | Simvastatin results in increased expression of LPL protein | 2009092 |
| C009277 | sodium arsenate | sodium arsenate results in decreased expression of LPL mRNA | 16882884|2392266 |
| C009277 | sodium arsenate | sodium arsenate analog results in decreased expression of LPL mRNA | 23221991 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of and affects the splicing of LPL mRNA | 25879800 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of LPL mRNA | 16507464 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of LPL mRNA | 23221991 |
| C016104 | sodium bichromate | sodium bichromate results in increased expression of LPL mRNA | 25993096 |
| D017673 | Sodium Chloride, Dietary | "[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA" | 22228705 |
| D053260 | Soot | Soot results in increased expression of LPL mRNA | 26551751 |
| C075117 | squalestatin 1 | squalestatin 1 results in decreased expression of LPL mRNA | 27225895 |
| C075117 | squalestatin 1 | squalestatin 1 results in decreased expression of LPL mRNA | 27225895 |
| D013311 | Streptozocin | [1-Deoxynojirimycin co-treated with Polysaccharides] inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA] | 25446853 |
| D013311 | Streptozocin | [Dietary Fats co-treated with Streptozocin] results in decreased expression of LPL mRNA | 25446853 |
| D013311 | Streptozocin | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D013311 | Streptozocin | myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein] | 25240712 |
| D013311 | Streptozocin | [Streptozocin co-treated with Cadmium] results in decreased activity of LPL protein | 25240712 |
| D013311 | Streptozocin | [Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein | 20696151 |
| D013311 | Streptozocin | [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D013311 | Streptozocin | tetrahydrocurcumin results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of LPL mRNA | 15953391 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of LPL mRNA | 14699072 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR1 protein] results in increased expression of LPL mRNA | 19059307 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of LPL protein | 3108557 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of LPL mRNA | 17555576|2093736 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of LPL mRNA | 20106945 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LPL mRNA | 28011154 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of LPL mRNA] | 18827440 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased activity of LPL protein] | 9414485 |
| D013749 | Tetrachlorodibenzodioxin | Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of LPL protein] | 9414485 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LPL mRNA | 21570461|2637764 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPL mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of LPL mRNA | 25975270 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LPL mRNA] | 16054899 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased activity of LPL protein | 9414485 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of LPL mRNA | 17942748|7537747 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LPL mRNA | 15800033|1611410 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of LPL mRNA | 23238561 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LPL mRNA | 20959002 |
| D013752 | Tetracycline | Tetracycline results in increased expression of LPL mRNA | 17522070 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of LPL protein | 18435438 |
| D013755 | Tetradecanoylphorbol Acetate | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LPL mRNA | 19840844 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LPL mRNA | 25613284 |
| C096277 | tetrahydrocurcumin | [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| C096277 | tetrahydrocurcumin | tetrahydrocurcumin results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D013806 | Theophylline | Theophylline results in increased expression of LPL mRNA | 16083514 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of LPL mRNA | 23411599 |
| C423915 | TO-901317 | [alitretinoin co-treated with TO-901317] results in increased expression of LPL mRNA | 16142410 |
| C423915 | TO-901317 | TO-901317 results in increased expression of LPL mRNA | 16142410 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of LPL mRNA | 22363418 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of LPL mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in increased expression of LPL mRNA | 25729387 |
| C496197 | trans-10,cis-12-conjugated linoleic acid | "trans-10,cis-12-conjugated linoleic acid results in decreased expression of LPL mRNA" | 16988111 |
| D014212 | Tretinoin | Tretinoin results in increased expression of LPL mRNA | 21934132 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of LPL mRNA | 16368784 |
| D014212 | Tretinoin | troglitazone inhibits the reaction [Tretinoin results in decreased expression of LPL mRNA] | 16368784 |
| C032910 | triadimefon | triadimefon results in increased expression of LPL mRNA | 26705709 |
| C011559 | tributyltin | tributyltin results in increased expression of LPL mRNA | 28011154 |
| C011559 | tributyltin | tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPL mRNA] | 22197818 |
| C011559 | tributyltin | tributyltin results in increased expression of LPL mRNA | 23322813|2451344 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of LPL mRNA | 24935251 |
| D014260 | Triclosan | Triclosan results in decreased expression of LPL mRNA | 22726953 |
| C053549 | triflumizol | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA] | 23086663 |
| C053549 | triflumizol | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of LPL mRNA | 23086663 |
| C053549 | triflumizol | T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA] | 23086663 |
| C053549 | triflumizol | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPL mRNA | 23086663 |
| D014280 | Triglycerides | [bisphenol A results in decreased expression of LPL mRNA] which affects the abundance of Triglycerides | 22662114 |
| D014280 | Triglycerides | LPL protein results in increased abundance of Triglycerides | 18698144 |
| D014280 | Triglycerides | [LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides | 15910848 |
| D014280 | Triglycerides | orlistat inhibits the reaction [[LPL protein results in increased hydrolysis of Triglycerides] which results in increased uptake of Triglycerides] | 15910848 |
| D014280 | Triglycerides | [orlistat results in decreased activity of LPL protein] which affects the uptake of Triglycerides | 12388125 |
| D014280 | Triglycerides | [Bezafibrate results in increased activity of LPL protein] which results in decreased abundance of Triglycerides | 9006809 |
| D014280 | Triglycerides | [Gemfibrozil results in increased activity of LPL protein] which results in decreased abundance of Triglycerides | 9006809 |
| D014280 | Triglycerides | [[Fibric Acids results in increased expression of LPL] co-treated with [Fibric Acids results in decreased expression of APOC3]] results in decreased abundance of Triglycerides | 11123853 |
| C005445 | triphenyl phosphate | triphenyl phosphate results in decreased expression of LPL mRNA | 26898711 |
| C005445 | triphenyl phosphate | triphenyl phosphate results in increased expression of LPL mRNA | 23306105 |
| C005445 | triphenyl phosphate | triphenyl phosphate results in increased expression of LPL mRNA | 28934090 |
| C005445 | triphenyl phosphate | triphenyl phosphate results in increased expression of LPL mRNA | 28163246 |
| C030665 | triphenyltin | triphenyltin results in decreased expression of LPL mRNA | 24177218 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of LPL mRNA" | 23306105 |
| C031324 | tris(chloroethyl)phosphate | tris(chloroethyl)phosphate results in increased expression of LPL mRNA | 27776230 |
| C057693 | troglitazone | [troglitazone co-treated with INS protein] results in increased expression of LPL mRNA | 21967882 |
| C057693 | troglitazone | [1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of LPL mRNA | 27003841 |
| C057693 | troglitazone | troglitazone results in increased expression of LPL protein | 10233209 |
| C057693 | troglitazone | [troglitazone results in increased expression of LPL protein] which results in increased metabolism of Lipids | 10233209 |
| C057693 | troglitazone | [troglitazone co-treated with Diethylstilbestrol] results in increased expression of LPL protein | 22710028 |
| C057693 | troglitazone | troglitazone inhibits the reaction [Calcitriol results in decreased expression of LPL mRNA] | 16368784 |
| C057693 | troglitazone | troglitazone inhibits the reaction [Tretinoin results in decreased expression of LPL mRNA] | 16368784 |
| C057693 | troglitazone | troglitazone results in increased expression of LPL mRNA | 10233209|1912227 |
| C057693 | troglitazone | troglitazone results in increased expression of LPL protein | 10233209 |
| C057693 | troglitazone | troglitazone results in increased expression of LPL mRNA | 21967882 |
| C057693 | troglitazone | troglitazone results in decreased expression of LPL mRNA | 21515302 |
| C057693 | troglitazone | BMP2 protein promotes the reaction [troglitazone results in increased expression of LPL mRNA] | 19122273 |
| C057693 | troglitazone | [troglitazone co-treated with TNF protein] results in decreased expression of LPL mRNA | 12732648 |
| C022884 | undecane | undecane results in increased expression of LPL protein | 17337753 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPL mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of LPL mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of LPL mRNA | 23179753|2571616 |
| D000068756 | Valsartan | [Valsartan co-treated with AGT protein] results in increased activity of LPL protein | 18640387 |
| D000068756 | Valsartan | Valsartan results in increased activity of LPL protein | 18640387 |
| D014640 | Vancomycin | Vancomycin results in increased expression of LPL mRNA | 18930951 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of LPL gene | 25560391 |
| D000069470 | Venlafaxine Hydrochloride | Venlafaxine Hydrochloride results in increased expression of LPL mRNA | 25423262 |
| C030106 | very low density lipoprotein triglyceride | LPL protein results in increased hydrolysis of very low density lipoprotein triglyceride | 18435438 |
| C030106 | very low density lipoprotein triglyceride | "[LPL protein results in increased hydrolysis of very low density lipoprotein triglyceride] which results in increased abundance of Fatty Acids, Unsaturated" | 18435438 |
| C030106 | very low density lipoprotein triglyceride | orlistat inhibits the reaction [very low density lipoprotein triglyceride results in increased activity of LPL protein] | 12573449 |
| C030106 | very low density lipoprotein triglyceride | very low density lipoprotein triglyceride affects the reaction [LPL protein results in decreased activity of TNF protein] | 15994321 |
| C030106 | very low density lipoprotein triglyceride | very low density lipoprotein triglyceride results in increased activity of LPL protein | 12573449 |
| C025643 | vinclozolin | vinclozolin affects the expression of LPL mRNA | 19015723 |
| C025643 | vinclozolin | vinclozolin results in increased expression of LPL mRNA | 22570695|2386920 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of LPL mRNA | 26682919 |
| D009536 | Niacinamide | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D009536 | Niacinamide | [Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein | 20696151 |
| D009536 | Niacinamide | [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| D009536 | Niacinamide | tetrahydrocurcumin results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LPL protein] | 20696151 |
| C111237 | vorinostat | vorinostat results in decreased expression of LPL mRNA | 27188386 |
| D015016 | Yohimbine | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of LPL mRNA | 28843594 |
| D015215 | Zidovudine | Zidovudine affects the expression of LPL mRNA | 20032539 |
| D015215 | Zidovudine | Zidovudine results in decreased expression of LPL mRNA | 16894629 |
| D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of LPL mRNA | 11741158 |
| D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of LPL mRNA | 11741158 |
| D015215 | Zidovudine | Zidovudine results in decreased expression of LPL mRNA | 11741158 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of LPL mRNA | 20857495 |
| D015032 | Zinc | Zinc affects the expression of LPL mRNA | 17181878 |
| C013738 | zingerone | zingerone inhibits the reaction [Ethanol results in decreased activity of LPL protein] | 28442378 |